Bevacizumab for the treatment of neovascular age related macular degeneration
- PMID: 20538636
- DOI: 10.1136/bmj.c2834
Bevacizumab for the treatment of neovascular age related macular degeneration
Comment in
-
Bevacizumab and ranibizumab. Bevacizumab and the inverse postcode lottery.BMJ. 2010 Jul 13;341:c3718. doi: 10.1136/bmj.c3718. BMJ. 2010. PMID: 20627986 No abstract available.
Comment on
-
Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study.BMJ. 2010 Jun 9;340:c2459. doi: 10.1136/bmj.c2459. BMJ. 2010. PMID: 20538634 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical